A BILL 
To amend title XVIII of the Social Security Act to provide 
for coverage and payment of Alpha-1 Antitrypsin Defi-
ciency Disorder treatment under part B of such title, 
and for other purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘John W. Walsh Alpha- 
4
1 Home Infusion Act of 2022’’. 
5
17:29 Apr 11, 2022
H7346
2 
•HR 7346 IH
SEC. 2. MEDICARE COVERAGE OF ALPHA-1 ANTITRYPSIN 
1
DISORDER TREATMENT. 
2
(a) IN GENERAL.—Section 1861 of the Social Secu-
3
rity Act (42 U.S.C. 1395x) is amended— 
4
(1) in subsection (s)(2)— 
5
(A) by striking ‘‘and’’ at the end of sub-
6
paragraph (GG); 
7
(B) by inserting ‘‘and’’ at the end of sub-
8
paragraph (HH); and 
9
(C) by inserting at the end the following 
10
new subparagraph: 
11
‘‘(II) Alpha-1 Antitrypsin Deficiency Dis-
12
order treatment (as defined in subsection 
13
(lll));’’; and 
14
(2) by adding at the end the following new sub-
15
section: 
16
‘‘(lll) ALPHA-1
ANTITRYPSIN
DEFI-
17
CIENCY DISORDER TREATMENT.—(1) The 
18
term ‘Alpha-1 Antitrypsin Deficiency Dis-
19
order treatment’ means augmentation ther-
20
apy (as defined in paragraph (2)(C)) fur-
21
nished by qualified home infusion therapy 
22
suppliers (as defined in paragraph (2)(D)) 
23
which are furnished in the individual’s 
24
home (as defined in paragraph (2)(B)) to 
25
an individual— 
26
17:29 Apr 11, 2022
H7346
3 
•HR 7346 IH
‘‘(A) who is under the care of an applicable 
1
provider; 
2
‘‘(B) who is enrolled under both parts A 
3
and B of this title, and is not enrolled in an 
4
MA plan under part C of such title; and 
5
‘‘(C) who requires augmentation therapy 
6
(as defined in paragraph (2)(C)). 
7
‘‘(2) For purposes of this subsection: 
8
‘‘(A) 
The 
term 
‘applicable 
provider’ 
9
means— 
10
‘‘(i) a physician; 
11
‘‘(ii) a nurse practitioner; and 
12
‘‘(iii) a physician assistant. 
13
‘‘(B) The term ‘home’ means a place of 
14
residence used as the home of an individual (as 
15
defined for purposes of subsection (n)). 
16
‘‘(C) The term ‘augmentation therapy’ 
17
means an Alpha-1 Proteinase Inhibitor indi-
18
cated for chronic augmentation and mainte-
19
nance therapy in adults with clinical evidence of 
20
emphysema due to severe hereditary deficiency 
21
of Alpha-1 Antitrypsin. 
22
‘‘(D) The term ‘qualified home infusion 
23
therapy supplier’ has the meaning given such 
24
term in subsection (iii)(3)(D)(i).’’. 
25
17:29 Apr 11, 2022
H7346
4 
•HR 7346 IH
(b) PAYMENT FOR INTRAVENOUS ADMINISTRATION 
1
KITS
AND
NURSING
SERVICES
FOR
ALPHA-1 
2
ANTITRYPSIN
DEFICIENCY
DISORDER
TREATMENT.— 
3
Section 1834 of the Social Security Act (42 U.S.C. 
4
1395m) is amended by adding at the end the following 
5
new subsection: 
6
‘‘(z) PAYMENT FOR INTRAVENOUS ADMINISTRATION 
7
KITS
AND
NURSING
SERVICES
FOR
ALPHA-1 
8
ANTITRYPSIN DEFICIENCY DISORDER TREATMENT.—The 
9
Secretary shall implement a payment system under which 
10
payment is made under this title to a qualified home infu-
11
sion 
therapy 
supplier 
(as 
defined 
in 
section 
12
1861(lll)(3)(D)) for intravenous administration kits and 
13
nursing services for up to 2 hours of care by a qualified 
14
home infusion therapy supplier in coordination with the 
15
furnishing of augmentation therapy (as defined in section 
16
1861(lll)(2)(C)).’’. 
17
(c) CONFORMING AMENDMENTS.— 
18
(1) 
PAYMENT
REFERENCE.—Section 
19
1833(a)(1) of the Social Security Act (42 U.S.C. 
20
1395l(a)(1)) is amended— 
21
(A) by striking ‘‘and’’ before ‘‘(DD)’’; and 
22
(B) by inserting before the semicolon at 
23
the end the following: ‘‘, and (EE) with respect 
24
to intravenous administration kits and nursing 
25
17:29 Apr 11, 2022
H7346
5 
•HR 7346 IH
services described in section 1834(z) for Alpha- 
1
1 Antitrypsin Disorder treatment (as defined in 
2
subsection (lll)(1)), the amount paid for such 
3
kits and services shall be an amount equal to 
4
80 percent of the lesser of the actual charge for 
5
the services or the amount determined under 
6
section 1834(z)’’. 
7
(2) DIRECT PAYMENT.—The first sentence of 
8
section 1842(b)(6) of the Social Security Act (42 
9
U.S.C. 1395u(b)(6)) is amended— 
10
(A) by striking ‘‘and’’ before ‘‘(J)’’; and 
11
(B) by inserting before the period at the 
12
end the following: ‘‘, and (K) in the case of in-
13
travenous administration kits and nursing serv-
14
ices described in section 1834(z), payment shall 
15
be made to the qualified home infusion therapy 
16
supplier 
(as 
defined 
in 
section 
17
1861(lll)(2)(D))’’. 
18
(3) EXCLUSION
FROM
HOME
HEALTH
SERV-
19
ICES.—Section 1861(m) of the Social Security Act 
20
(42 U.S.C. 1395x(m)) is amended, in the first sen-
21
tence, by inserting the following before the period at 
22
the end: ‘‘and intravenous administration kits and 
23
nursing services described in section 1834(z) for 
24
17:29 Apr 11, 2022
H7346
6 
•HR 7346 IH
Alpha-1 Antitrypsin Deficiency Disorder treatment 
1
(as defined in subsection (lll)(1))’’. 
2
(d) EFFECTIVE DATE.—The amendments made by 
3
this section shall apply to items and services furnished on 
4
or after January 1, 2023. 
5
Æ 
17:29 Apr 11, 2022
H7346
